Holen Sie sich die Stockscreener-App
2.13
1.39%
-0.03
Handel nachbörslich:
2.17
0.04
+1.88%
Schlusskurs vom Vortag:
$2.16
Offen:
$2.14
24-Stunden-Volumen:
139.92K
Relative Volume:
0.55
Marktkapitalisierung:
$269.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-70.78M
KGV:
-3.8036
EPS:
-0.56
Netto-Cashflow:
$-61.27M
1W Leistung:
+5.45%
1M Leistung:
+7.04%
6M Leistung:
+198.78%
1J Leistung:
+33.12%
1-Tages-Spanne:
$2.02
$2.19
1-Wochen-Bereich:
$1.97
$2.20
52-Wochen-Spanne:
$0.62
$2.54
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Firmenname
Nautilus Biotechnology Inc
Sektor
Branche
Telefon
206-333-2001
Adresse
2701 EASTLAKE AVE EAST, SEATTLE
Compare NAUT vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
2.13 | 272.82M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2022-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Eingeleitet | Goldman | Neutral |
| 2021-07-13 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten
3 Penny Stocks With Market Caps Over $50M To Watch - simplywall.st
Earnings Miss: Does Nautilus Biotechnology Inc have strong fundamentalsStop Loss & Real-Time Buy Signal Notifications - baoquankhu1.vn
Nautilus Biotechnology explores multiomics to mitigate space travel effects - Traders Union
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - The Manila Times
Risk Hedge: Is GP Act III Acquisition Corp Equity Warrant stock suitable for long term investing - baoquankhu1.vn
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Update - MarketBeat
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with the Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson's Disease - marketscreener.com
Nautilus Biotechnology announces research collab with WCM-Q, MJFF - TipRanks
Nautilus Biotechnology and Weill Cornell Medicine-Qatar - GlobeNewswire
Nautilus Biotechnology Insider Confidence Rewarded, Stock Hits US$275m Market Cap - 富途牛牛
What’s the MACD signal for Nautilus Biotechnology Inc.Earnings Recap Report & AI Enhanced Trading Signals - mfd.ru
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 6.3%What's Next? - MarketBeat
Analyzing Nautilus Biotechnology (NASDAQ:NAUT) and OnKure Therapeutics (NASDAQ:OKUR) - Defense World
Buyout Rumor: Why is US GoldMining Inc stock going downJuly 2025 EndofMonth & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Analyst Upgrade: Is Nautilus Biotechnology Inc stock a smart retirement pickMarket Trend Report & Risk Controlled Daily Plans - baoquankhu1.vn
Published on: 2026-01-14 06:58:20 - baoquankhu1.vn
Nautilus Biotechnology launches Iterative Mapping Early Access Program - Traders Union
Why Nautilus Biotechnology Inc. stock could rally in 2025GDP Growth & Free Safe Capital Growth Stock Tips - Улправда
Will Nautilus Biotechnology Inc. stock deliver consistent dividendsWeekly Profit Report & Risk Controlled Swing Alerts - Улправда
Why analysts upgrade Nautilus Biotechnology Inc. stock2025 Earnings Surprises & Risk Adjusted Buy and Sell Alerts - Улправда
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay - MarketScreener
Nautilus Biotechnology Launches Early Access Program for - GlobeNewswire
Nautilus Biotechnology Insiders May Regret Not Buying More, Market Cap Hits US$236m - simplywall.st
3 Penny Stocks With Market Caps Under $700M - simplywall.st
Will Nautilus Biotechnology Inc. stock outperform tech sector in 20252026 world cup usa national team qualification defensive leaders set piece tactics group prediction preview - ulpravda.ru
Corient Private Wealth LLC Acquires 390,000 Shares of Nautilus Biotechnology, Inc. $NAUT - Defense World
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) boasts of bullish insider sentiment with 33% ownership and they have been buying lately - Yahoo Finance
Nautilus Biotechnology Faces Nasdaq Delisting Risk Amid Compliance Challenges - MSN
Aug Fed Impact: Is Nautilus Biotechnology Inc stock attractive for income investorsJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - moha.gov.vn
How buybacks impact Nautilus Biotechnology Inc. stock valueJuly 2025 Trends & Verified Swing Trading Watchlists - Улправда
Will Nautilus Biotechnology Inc. stock attract more institutional investors - Улправда
Published on: 2025-12-20 14:57:12 - moha.gov.vn
Nautilus Biotechnology Earnings Notes - Trefis
Why Nautilus Biotechnology Inc. stock remains on buy lists2025 Market WrapUp & Community Consensus Picks - bolumsonucanavari.com
Is Nautilus Biotechnology Inc. stock a safe buy before earnings2025 Analyst Calls & Long-Term Growth Stock Strategies - DonanımHaber
ETF Watch: Is Nautilus Biotechnology Inc. stock a safe buy before earningsJuly 2025 Retail & Step-by-Step Trade Execution Guides - DonanımHaber
Is Nautilus Biotechnology Inc. stock supported by strong fundamentalsJuly 2025 Highlights & Verified Swing Trading Watchlist - Улправда
Is Nautilus Biotechnology Inc. stock a buy before product launches2025 Volatility Report & Capital Efficiency Focused Ideas - Улправда
Nautilus Biotechnology drives innovation in proteomics space - Traders Union
Nautilus Biotechnology (NAUT) Stock Analysis Report | Financials & Insights - Benzinga
Nautilus Biotechnology: Divergent Signals from Investors and Analysts - AD HOC NEWS
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.5%Here's What Happened - MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.5% – Here’s What Happened - Defense World
Is Nautilus Biotechnology Inc a good long term investmentEconomic Indicators Overview & Small Budget Portfolio Growth - earlytimes.in
Penny Stocks To Consider In December 2025 - simplywall.st
Investment Report: Will Nautilus Biotechnology Inc. stock attract more institutional investorsEarnings Growth Report & Technical Buy Zone Confirmations - moha.gov.vn
Adversity is less terrifying than hope: Nautilus Biotechnology Inc (NAUT) - setenews.com
Advancing next-generation proteomics with single-molecule Iterative Mapping - SelectScience
There is no way Nautilus Biotechnology Inc (NAUT) can keep these numbers up - Setenews
Advanced analytics toolkit walkthrough for Nautilus Biotechnology Inc.2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
What dividend safety score for Nautilus Biotechnology Inc. stockMarket Growth Report & Low Volatility Stock Recommendations - newser.com
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):